SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
- 25 June 1999
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 1 (4) , 193-199
- https://doi.org/10.1038/12013
Abstract
Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin–CDK complexes. However, the ubiquitin–protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein–substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27. Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.Keywords
This publication has 43 references indexed in Scilit:
- The ubiquitin-proteasome pathway: on protein death and cell lifeThe EMBO Journal, 1998
- Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesisTrends in Genetics, 1998
- Regulation of G1 PhasePublished by Springer Nature ,1998
- Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexesOncogene, 1997
- Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1The EMBO Journal, 1997
- Cancer prognostics: Past, present and p27Nature Medicine, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Protein marker linked with poor cancer outcomePublished by BMJ ,1997
- A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesisTrends in Cell Biology, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995